Can weight loss injections cause mood swings? Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), are increasingly prescribed for weight management in the UK. Whilst generally well-tolerated, some patients report mood changes during treatment. Currently, no established causal link exists between GLP-1 medications and mood swings in official prescribing information. However, rapid weight loss, caloric restriction, gastrointestinal side effects, and blood glucose fluctuations may all influence emotional wellbeing. Understanding potential mood-related effects and when to seek medical advice ensures safe, effective treatment.

Can Weight Loss Injections Cause Mood Swings?

Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK. Whilst these medications are generally well-tolerated and effective, patients and healthcare professionals have raised concerns about potential effects on mood and emotional wellbeing.

Currently, there is no established causal link between GLP-1 medications and mood swings in the official prescribing information. This position is supported by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC), which in 2024 found no evidence of a causal association between GLP-1 receptor agonists and suicidal or self-harm thoughts, though monitoring continues.

GLP-1 receptor agonists primarily work by mimicking the incretin hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These medications act on GLP-1 receptors both peripherally and centrally, including in brain regions involved in appetite regulation and reward pathways, though a direct impact on mood regulation has not been established.

Some patients report experiencing mood changes, irritability, or emotional fluctuations whilst using these treatments. It remains unclear whether such symptoms arise from the medication itself, the physiological stress of rapid weight loss, caloric restriction, changes in eating patterns, or pre-existing mental health conditions. Rapid weight loss of any cause can affect hormone levels, blood sugar stability, and nutritional status—all factors that may influence mood and emotional regulation.

The MHRA continues to monitor post-marketing surveillance data for all adverse effects, including neuropsychiatric symptoms. Healthcare professionals should maintain awareness of this possibility and encourage open communication with patients about any mood-related concerns during treatment. Individual responses to medication vary considerably, and what affects one person may not affect another.

Common Emotional Side Effects of GLP-1 Medications

Whilst mood swings are not listed as a common adverse effect in the Summary of Product Characteristics for GLP-1 receptor agonists, patients may experience a range of emotional and psychological changes during treatment. Understanding the broader context of potential side effects helps distinguish between direct drug effects and secondary consequences of weight loss.

Gastrointestinal symptoms represent the most frequently reported adverse effects of GLP-1 medications, including:

• Nausea and vomiting (very common, affecting up to 44% of patients in clinical trials for semaglutide 2.4mg)

• Diarrhoea or constipation

• Abdominal discomfort and bloating

• Reduced appetite and early satiety

These persistent physical symptoms can understandably affect mood, energy levels, and quality of life, potentially leading to irritability, frustration, or low mood. The discomfort associated with gastrointestinal side effects may be misinterpreted as primary mood disturbance.

Hypoglycaemia (low blood sugar) is uncommon with GLP-1 receptor agonist monotherapy in people without diabetes. However, the risk increases significantly when combined with insulin or sulfonylureas. Symptoms of hypoglycaemia include anxiety, irritability, confusion, tremor, and mood changes. Patients with diabetes should be educated to recognise these symptoms and understand appropriate management strategies.

Some patients report fatigue and reduced energy, which may relate to caloric restriction or rapid weight loss rather than direct medication effects. Tiredness can significantly impact emotional resilience and mood stability. If persistent, clinical assessment may be warranted to rule out other causes.

Changes in relationship with food and eating patterns may also affect psychological wellbeing. The dramatic reduction in appetite can feel unsettling for some individuals, whilst others may experience anxiety about regaining weight or maintaining their new eating habits. These psychological adjustments require recognition and, where appropriate, professional support.

Managing Mood Changes While Using Weight Loss Injections

If you experience mood changes whilst using weight loss injections, several practical strategies can help manage symptoms and improve overall wellbeing during treatment.

Maintain regular communication with your healthcare team. Report any mood changes, irritability, or emotional symptoms to your GP or prescribing clinician. They can assess whether symptoms might relate to the medication, dosage, or other factors. Never discontinue prescribed medication without medical guidance.

Optimise nutritional intake despite reduced appetite. Whilst eating less is the intended effect, ensure your diet remains balanced and nutrient-dense. Follow the NHS Eatwell Guide principles, focusing on:

• Adequate protein intake to preserve muscle mass

• Complex carbohydrates for stable blood glucose levels

• Healthy fats including omega-3 sources

• Plenty of fruits and vegetables for essential vitamins and minerals

Consider consultation with a registered dietitian who can provide personalised nutrition guidance during weight loss treatment.

Monitor blood glucose levels if you have diabetes. If you have diabetes or are taking medications that can cause hypoglycaemia (such as insulin or sulfonylureas), check your blood glucose regularly and discuss medication adjustments with your healthcare team. Preventing glucose fluctuations helps maintain stable mood and energy.

Prioritise sleep hygiene and stress management. Adequate sleep (7-9 hours nightly) and stress-reduction techniques such as mindfulness, gentle exercise, or relaxation practices support emotional regulation. Physical activity, even light walking, can improve mood through endorphin release and may help manage some gastrointestinal side effects.

Address gastrointestinal symptoms proactively. Since nausea and digestive discomfort can affect mood, work with your healthcare provider to manage these effects through dietary modifications, eating smaller frequent meals, avoiding trigger foods, or considering slower dose titration as per the medication guidance. Some symptoms improve after the initial weeks of treatment as your body adjusts.

If mood symptoms persist, your GP may refer you to NHS Talking Therapies for additional support with anxiety or low mood.

When to Seek Medical Advice About Mood Symptoms

Whilst mild mood fluctuations may occur during any significant lifestyle or medication change, certain symptoms warrant prompt medical attention. Understanding when to contact your GP or healthcare provider ensures your safety and wellbeing during treatment.

Seek urgent medical advice if you experience:

• Severe or persistent low mood lasting more than two weeks

• Thoughts of self-harm or suicide—contact your GP immediately, call NHS 111, attend A&E, or call 999 if you are in immediate danger

• Significant anxiety or panic attacks that interfere with daily functioning

• Marked personality changes or behaviour that concerns you or your family

• Symptoms of severe depression, including loss of interest in activities, feelings of worthlessness, or inability to function

For immediate support, you can also contact the Samaritans (116 123) or your local NHS urgent mental health helpline.

Contact your GP or prescribing clinician if you notice:

• Mood changes that feel disproportionate or unusual for you

• Irritability or emotional instability affecting relationships or work

• Anxiety that develops or worsens after starting treatment

• Sleep disturbances, particularly insomnia or excessive sleeping

• Symptoms of hypoglycaemia if you have diabetes (confusion, tremor, sweating, rapid heartbeat)

Your healthcare provider can assess whether symptoms relate to the medication, underlying mental health conditions, or other factors. They may recommend slower dose titration, temporary dose reduction, psychological support, or alternative treatment options. NICE guidance (CG189) emphasises the importance of holistic care during weight management, including attention to mental health and psychological wellbeing.

If you have a pre-existing mental health condition or eating disorder, inform your prescriber before starting weight loss injections. More frequent monitoring may be appropriate, and coordination with your mental health team ensures comprehensive care. Remember that effective weight management involves not just physical health but emotional and psychological wellbeing—all aspects deserve equal attention and professional support.

If you suspect you're experiencing side effects from your medication, report them through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Frequently Asked Questions